Navigation Links
d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees

(PRWEB) March 19, 2013

In 1994, the FDA approved the first Zimmer NexGen Knee replacement system which was touted as advancement in knee implants according to the Zimmer company website. The design of Zimmer NexGen Flex Knee differs from traditional knee replacement systems due to it being manufactured using Trabecular Metal, a “porous metal,” and surgical cement as opposed to traditional materials (i). Marketed by Zimmer to have a 155 degree range of motion, the NexGen Flex Knee was intended to provide more flexibility over traditional knee implants (ii).

The law offices of d’Oliveira & Associates have posted a new infographic that provides current information regarding the Zimmer NexGen Flex Knee Replacement system and many safety concerns surrounding the device. Concerns addressed within the infographic include common side effects associated with the device, which may involve stiff joints, swelling or more serious effects like nerve damage (iii). Longevity of the devise and its possible failure rate is another issue examined by the infographic. Implanted knee devices are meant to last an average 10 to 20 years without incident and according to the American Academy of Orthopedic Surgeons many traditional systems last even longer than 20 years (iv). Based on court documents the Zimmer NexGen Flex Knee systems may have a higher chance of failure within in a shorter period of time then traditional knee implant devices (U.S. District Court of Northern Illinois under the multidistrict litigation (MDL) case number 2272).

In 2005, Zimmer consultant, Dr. Richard A. Berger, implanted 125 patients with the Zimmer NexGen Flex Knee device and according to the New York Times article, after follow-up X-rays showed the device had not fused properly and was loose Dr. Berger filed safety complaints with the Zimmer Company (v). By 2007 Dr. Berger had promptly stopped implanting patients with the Zimmer NexGen Flex Knee device (v). According to a 2010 SEC report filed by the company, the Zimmer NexGen CR-Flex Knee was the subject of a 108 patient study (The High Failure Rate of a High-Flex Total Knee Arthroplasty Design) conducted by Dr. Berger and Dr. Della Valle. The results of the study showed that the doctors “revised 9 (8.3%) patients for femoral loosening and pain (vi).” Additionally, “39 (36%) patients showed evidence of radiographic loosening and that ‘loosening and revision were not related to surgeon, approach or patient type (vi).’”

The Zimmer NexGen Flex Knee infographic provides a list of possible side effects as well as informing consumers of recalls for Zimmer knee products. Visit the Zimmer webpage and view the infographic here: Zimmer NexGen Knee Infographic.

If you or a loved one has been injured by a Zimmer NexGen Flex Knee, you may want to speak with a personal injury lawyer regarding a potential claim. A defective device lawyer familiar with new developments in the investigation of Zimmer knee products may be able to assist you in making important personal and legal decisions. Our firm is working with some of the leading Zimmer lawyers in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d'Oliveira & Associates Helps Massachusetts Man Receive $100,000 in Auto Accident Settlement
2. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. D'Oliveira & Associates Now Offers a No Win No Fee Promise in Zithromax Cases
5. d'Oliveira & Associates Helps Fall River, MA Teenager Receive $38,500 in Auto Accident Settlement
6. d'Oliveira & Associates Notes the Announcement of Zoloft Birth Defects Multidistrict Litigation (MDL) Set to Start in Mid-September 2014
7. The Law Firm of d'Oliveira and Associates Now Offers a No Win - No Free Promise in Nexium Cases
8. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
9. d'Oliveira & Associates Helps Newport Woman Receive $150,000 Settlement for Auto Accident; Case: MI-11889
10. d'Oliveira & Associates Helps Rhode Island Estate Receive the Maximum Compensation Under RI Law of $250,000 Settlement for Fatal Auto Accident
11. d'Oliveira & Associates Helps Westport, MA Man Receive $100,000 Settlement for Reckless Driving Accident
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology: